Company Analysis - Vyome Holdings, Inc. (HIND) has a Return on Invested Capital (ROIC) of -369.22%, significantly below its Weighted Average Cost of Capital (WACC) of 4.13%, indicating poor capital utilization [1][6] - Digital Brands Group, Inc. (DBGI) has a less negative ROIC of -63.30% and a WACC of 38.33%, resulting in a ROIC to WACC ratio of -1.65, suggesting relatively better capital efficiency compared to Vyome [2][6] - Palisade Bio, Inc. (PALI) shows a negative ROIC of -309.15% against a WACC of 11.16%, leading to a ROIC to WACC ratio of -27.70, indicating struggles in generating returns [3][6] - Ensysce Biosciences, Inc. (ENSC) has an even more negative ROIC of -874.14% with a WACC of 41.64%, resulting in a ROIC to WACC ratio of -20.99, highlighting significant challenges in capital utilization [4][6] - Grom Social Enterprises, Inc. (GROM) and NeuroBo Pharmaceuticals, Inc. (NRBO) exhibit negative ROICs of -59.49% and -269.72%, respectively, with WACCs of 33.38% and 5.00%, indicating widespread issues of negative returns across the peer group [5][6] Industry Overview - The analysis indicates a trend of negative ROIC across multiple companies within the industry, suggesting potential industry-wide challenges in capital efficiency and return generation [2][5][6]
Vyome Holdings, Inc. (HIND) Capital Utilization Challenges
Financial Modeling Prep·2025-11-22 17:00